JPMorgan Starts Spyre (SYRE) at Overweight

October 1, 2026 2:42 AM

JPMorgan analyst Hardik Parikh initiates coverage on Spyre (NASDAQ: SYRE) with a Overweight rating and a price target of $110.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found